Prostate Cancer – Risk of Recurrence
Test to assess your risk of prostate cancer recurrence
The following test will assess Postate Cancer – Risk of Recurrence
Oncotype DX® Prostate Cancer Assay
Test available from: Oncotypeiq
The Oncotype DX Genomic Prostate Score (GPS) assay is the only genomic assay designed for men with clinically low-risk cancer to help make treatment decisions at the time of diagnosis. The assay analyzes prostate cancer gene activity to predict disease aggressiveness.
Article source: Oncotypeiq
Updated 2023